Telomerase: A target for cancer therapeutics
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Cell Biology,Oncology
Reference103 articles.
1. Use of transcriptional regulatory sequences of telomerase (hTER and hTERT) for selective killing of cancer cells;Abdul-Ghani;Mol. Ther.,2000
2. Telomerase regulation: not just flipping the switch;Aisner;Curr. Opin. Genet. Dev.,2002
3. Telomere states and cell fates;Blackburn;Nature,2000
4. Extension of life-span by introduction of telomerase into normal human cells;Bodnar;Science,1998
5. Limited proliferation and telomere dysfunction following telomerase inhibition in immortal murine fibroblasts;Boklan;Cancer Res.,2002
Cited by 293 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Genome-Wide Characterization and Digital Expression Analysis of the TELOMERASE REVERSE TRANSCRIPTASE (TERT) Gene in Arabidopsis thaliana;Biology Bulletin;2023-10-10
2. Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA);Cancer Cell International;2023-09-07
3. Telomerase inhibition by MST-312 sensitises breast cancer cells to anti-cancer properties of Plumbagin;2023-05-31
4. Hyperpolarized δ-[1- 13C]gluconolactone imaging visualizes response to TERT or GABPB1 targeting therapy for glioblastoma;Scientific Reports;2023-03-30
5. Telomerase Inhibition by MST-312 Sensitizes Breast Cancer Cells to the Anti-cancer Properties of Plumbagin;Genome Integrity;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3